This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Jacobs, A. K. Search for Related Content PubMed Articles by Jacobs, A. K. Related Collections Acute coronary syndromes Catheter-based coronary and valvular interventions: other

Contemporary Reviews in Interventional Cardiology

Coronary Intervention in 2009

Are Women No Different Than Men?

Alice K. Jacobs, MD

From the Department of Medicine, Boston University School of Medicine and the Section of Cardiology, Boston Medical Center, Boston, Mass.

Correspondence to Alice K. Jacobs, MD, Section of Cardiology, Boston Medical Center, 88 E Newton Street, Boston, MA 02118. E-mail alice.jacobs@bmc.org

Key Words: angioplasty • coronary disease • women

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
Cardiovascular disease remains the leading cause of death in the United States in both women and men, and each year for more than 2 decades, more women than men have died (Figure 1). In 2006, 41.3 million women (34.9%) and 38.7 million men (37.6%) were living with cardiovascular disease, reflecting mortality in 454.6 thousand women and 409.9 thousand men in 2005, with coronary heart disease responsible for 1 of every 5 deaths overall. In fact, the lifetime risk of developing coronary heart disease after age 40 is 49% in men and 32% in women. Furthermore, it is estimated that in 2009, cardiovascular disease and stroke will cost the nation $475.3 billion.¹

View larger version (14K):   Figure 1. Cardiovascular mortality trends for males and females in the United States, 1979 to 2005. Reproduced with permission from Ref. 1, Copyright © 2009 American Heart Association.

 
Despite these sobering statistics, marked disparities in cardiovascular health and care, and specifically in the delivery and outcomes of coronary revascularization therapy, persist between women and men. Of the 1.3 million percutaneous coronary intervention (PCI) procedures performed in 2006, only 35% were performed in women,¹ despite the known benefits of this treatment, particularly in high-risk women with acute coronary syndromes (ACS)² and ST-segment elevation myocardial infarction (STEMI).^3,4 Moreover, for those women treated with PCI, unadjusted mortality (Figure 2) and (vascular and bleeding) complication rates (Figure 3) remain significantly higher than in men.^5,6

View larger version (14K):   Figure 2. In-hospital and late mortality rates in women versus men after PCI. . . . [Full Text of this Article]